Trial intelligence / Profile preview

Progesterone effects on periodontal microbiota and periodontal tissues

ChiCTR2400089666Phase 4Completed

Sponsor
Shengli Oilfield Central Hospital
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dydrogesterone in periodontitis and gingival disease (2 arms), sponsored by Shengli Oilfield Central Hospital. Primary endpoint: probing depth at 3 months. Started Sep 2024; status: completed.

02

Drugs

dydrogesterone
03

Conditions

periodontitisgingival disease

Beyond the preview

Go deeper on ChiCTR2400089666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400089666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call